Literature DB >> 27621509

Taking an Antibiotic Time-out: Utilization and Usability of a Self-Stewardship Time-out Program for Renewal of Vancomycin and Piperacillin-Tazobactam.

Christopher J Graber1, Makoto M Jones2, Peter A Glassman1, Charlene Weir3, Jorie Butler4, Kevin Nechodom3, Chad L Kay5, Amy E Furman5, Thuong T Tran6, Christopher Foltz6, Lori A Pollack7, Matthew H Samore3, Matthew Bidwell Goetz1.   

Abstract

BACKGROUND: Antibiotic time-outs can promote critical thinking and greater attention to reviewing indications for continuation.
OBJECTIVE: We pilot tested an antibiotic time-out program at a tertiary care teaching hospital where vancomycin and piperacillin-tazobactam continuation past day 3 had previously required infectious diseases service approval.
METHODS: The time-out program consisted of 3 components: (1) an electronic antimicrobial dashboard that aggregated infection-relevant clinical data; (2) a templated note in the electronic medical record that included a structured review of antibiotic indications and that provided automatic approval of continuation of therapy when indicated; and (3) an educational and social marketing campaign.
RESULTS: In the first 6 months of program implementation, vancomycin was discontinued by day 5 in 93/145 (64%) courses where a time-out was performed on day 4 versus in 96/199 (48%) 1 year prior (P = .04). Seven vancomycin continuations via template (5% of time-outs) were guideline-discordant by retrospective chart review versus none 1 year prior (P = .002). Piperacillin-tazobactam was discontinued by day 5 in 70/105 (67%) courses versus 58/93 (62%) 1 year prior (P = .55); 9 continuations (9% of time-outs) were guideline-discordant versus two 1 year prior (P = .06). A usability survey completed by 32 physicians demonstrated modest satisfaction with the overall program, antimicrobial dashboard, and renewal templates.
CONCLUSIONS: By providing practitioners with clinical informatics support and guidance, the intervention increased provider confidence in making decisions to de-escalate antimicrobial therapy in ambiguous circumstances wherein they previously sought authorization for continuation from an antimicrobial steward.

Entities:  

Keywords:  antibacterial agents; health education; hospital infections; inappropriate prescribing; piperacillin-tazobactam; vancomycin

Year:  2015        PMID: 27621509      PMCID: PMC4750836          DOI: 10.1310/hpj5011-1011

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  35 in total

1.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

2.  If not now, when? Seizing the moment for antibiotic stewardship.

Authors:  Lori A Pollack; Carolyn V Gould; Arjun Srinivasan
Journal:  Infect Control Hosp Epidemiol       Date:  2012-12-19       Impact factor: 3.254

Review 3.  Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis.

Authors:  Céire Costelloe; Chris Metcalfe; Andrew Lovering; David Mant; Alastair D Hay
Journal:  BMJ       Date:  2010-05-18

4.  Antibiotic treatment of children with sore throat.

Authors:  Jeffrey A Linder; David W Bates; Grace M Lee; Jonathan A Finkelstein
Journal:  JAMA       Date:  2005-11-09       Impact factor: 56.272

5.  Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection.

Authors:  Megan K Shaughnessy; William H Amundson; Michael A Kuskowski; Douglas D DeCarolis; James R Johnson; Dimitri M Drekonja
Journal:  Infect Control Hosp Epidemiol       Date:  2012-12-19       Impact factor: 3.254

6.  Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program.

Authors:  Harold C Standiford; Shannon Chan; Megan Tripoli; Elizabeth Weekes; Graeme N Forrest
Journal:  Infect Control Hosp Epidemiol       Date:  2012-04       Impact factor: 3.254

7.  Risk factors for Clostridium difficile infection.

Authors:  G E Bignardi
Journal:  J Hosp Infect       Date:  1998-09       Impact factor: 3.926

8.  Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship.

Authors:  Rebecca R Roberts; Bala Hota; Ibrar Ahmad; R Douglas Scott; Susan D Foster; Fauzia Abbasi; Shari Schabowski; Linda M Kampe; Ginevra G Ciavarella; Mark Supino; Jeremy Naples; Ralph Cordell; Stuart B Levy; Robert A Weinstein
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

9.  Understanding the determinants of antimicrobial prescribing within hospitals: the role of "prescribing etiquette".

Authors:  E Charani; E Castro-Sanchez; N Sevdalis; Y Kyratsis; L Drumright; N Shah; A Holmes
Journal:  Clin Infect Dis       Date:  2013-04-09       Impact factor: 9.079

10.  An analysis of clinical reasoning through a recent and comprehensive approach: the dual-process theory.

Authors:  Thierry Pelaccia; Jacques Tardif; Emmanuel Triby; Bernard Charlin
Journal:  Med Educ Online       Date:  2011-03-14
View more
  11 in total

1.  First-year results of an antibiotic stewardship program in a Greek tertiary care hospital.

Authors:  K Chrysou; O Zarkotou; S Kalofolia; P Papagiannakopoulou; G Chrysos; K Themeli-Digalaki; A Tsakris; S Pournaras
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-11-19       Impact factor: 3.267

2.  Decreases in Antimicrobial Use Associated With Multihospital Implementation of Electronic Antimicrobial Stewardship Tools.

Authors:  Christopher J Graber; Makoto M Jones; Matthew Bidwell Goetz; Karl Madaras-Kelly; Yue Zhang; Jorie M Butler; Charlene Weir; Ann F Chou; Sarah Y Youn; Matthew H Samore; Peter A Glassman
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

3.  Implementation of an Automatic 48-Hour Vancomycin Hard-Stop in a Pediatric Community Hospital.

Authors:  Mallory C Cowart; Danielle Miller; Federico R Laham; Alejandro Jordan-Villegas
Journal:  J Pediatr Pharmacol Ther       Date:  2022-02-09

4.  Clinical Impact of an Antibiotic Time Out Initiative at an Academic Medical Center.

Authors:  Amy Parks Taylor; Kelci Coe; Kurt Stevenson; Lynn Wardlow; Zeinab El Boghdadly; Erica Reed
Journal:  Hosp Pharm       Date:  2020-01-27

5.  A Scoping Review of the Use of Social and Behavioral Change in Acute Care Antimicrobial Stewardship Initiatives.

Authors:  Alice N Hemenway; David L DuBois
Journal:  Hosp Pharm       Date:  2021-02-01

Review 6.  Principles and Practice of Antibiotic Stewardship in the ICU.

Authors:  Chiagozie I Pickens; Richard G Wunderink
Journal:  Chest       Date:  2019-01-25       Impact factor: 9.410

7.  Social dynamics of a population-level dashboard for antimicrobial stewardship: A qualitative analysis.

Authors:  Peter Taber; Charlene Weir; Jorie M Butler; Christopher J Graber; Makoto M Jones; Karl Madaras-Kelly; Yue Zhang; Ann F Chou; Matthew H Samore; Matthew Bidwell Goetz; Peter A Glassman
Journal:  Am J Infect Control       Date:  2021-01-27       Impact factor: 2.918

8.  Reducing overuse of antibiotics at discharge home: A single-center mixed methods pilot study.

Authors:  Daniel L Giesler; Sarah Krein; Adamo Brancaccio; Daraoun Mashrah; David Ratz; Tejal Gandhi; Linda Bashaw; Jennifer Horowitz; Valerie Vaughn
Journal:  Am J Infect Control       Date:  2021-11-28       Impact factor: 4.303

Review 9.  Using theories and frameworks to understand how to reduce low-value healthcare: a scoping review.

Authors:  Gillian Parker; Nida Shahid; Tim Rappon; Monika Kastner; Karen Born; Whitney Berta
Journal:  Implement Sci       Date:  2022-01-20       Impact factor: 7.327

10.  Antimicrobial Time-Out for Vancomycin by Infectious Disease Physicians Versus Clinical Pharmacists: A Before-After Crossover Trial.

Authors:  Shinya Hasegawa; Yasuaki Tagashira; Shutaro Murakami; Yasunori Urayama; Akane Takamatsu; Yuki Nakajima; Hitoshi Honda
Journal:  Open Forum Infect Dis       Date:  2021-03-14       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.